Public Profile

Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc., a leading player in the pharmaceutical industry, is headquartered in the United States. Founded in 2008, the company has made significant strides in developing innovative pain management solutions, particularly focusing on abuse-deterrent formulations. With a commitment to addressing the opioid crisis, Collegium has positioned itself as a pioneer in creating safer alternatives for patients. The company’s flagship product, Xtampza ER, is an extended-release formulation of oxycodone designed to reduce the potential for misuse. Collegium's unique approach to pain management, combined with its robust pipeline of products, underscores its dedication to improving patient outcomes. With a strong market presence and a focus on responsible prescribing, Collegium Pharmaceutical continues to achieve notable milestones in the evolving landscape of pain management therapies.

DitchCarbon Score

How does Collegium Pharmaceutical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Collegium Pharmaceutical, Inc.'s score of 25 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Collegium Pharmaceutical, Inc.'s reported carbon emissions

Collegium Pharmaceutical, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their Scope 1, 2, or 3 emissions. The absence of emissions data suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. While no specific climate commitments or initiatives are outlined, it is essential for companies in the pharmaceutical sector to engage in sustainable practices and set measurable targets to reduce their carbon footprint. As the industry increasingly prioritises environmental responsibility, Collegium Pharmaceutical may consider adopting industry-standard climate commitments to enhance their sustainability profile in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Collegium Pharmaceutical, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Collegium Pharmaceutical, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Collegium Pharmaceutical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Endo Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Bausch Health Cos

CA
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

LTS Lohmann Therapie-Systeme AG

DE
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Ethypharm SAS

FR
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Zogenix, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Salix Pharmaceuticals Ltd.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers